Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-003742-32Phase 4Unknown
Phase 4, randomised, open-label trial in trigger finger, de Quervain's tenosynovitis and carpal tunnel syndrome (CTS) comparing Kenalog alone with Kenalog + lidocaine (2 arms). Primary endpoint: Pain at 1 hour after injection. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-003742-32.